HY01

N/A

Report date: 2023/01/07 18:44:54
NME

Base Information

Drug NameHY01
Drug Alias NameHY-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHearing Loss, SensorineuralDeafnessHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHeyu (Suzhou) Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHeyu (Suzhou) Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsDeafnessHearing Loss
Inactive IndicationsHearing Loss, Sensorineural

Other Information

ATC CodeN/A
Related LinksN/A